Emerald Advisers’s Dermira, Inc. DERM Stock Holding History

Emerald Advisers’s Portfolio DERM Stock Details DERM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-536,425	Closed	-$14.9M	–	276
2017 Q4	$14.9M	Buy	+536,425	New	+$14.2M	0.57%	69

Other funds holding DERM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Emerald Advisers's DERM Position: Q1 2018 in Review

Emerald Advisers sold out of Dermira, Inc. (DERM) in Q1 2018, closing a stake of 536,425 shares — an estimated $14.9M sold.

Emerald Advisers first reported a position in DERM in Q4 2017 and held it in 1 quarter. The position peaked at $14.9M in Q4 2017. 128 funds tracked by Wall St. Rank hold DERM as of Q1 2018.

Emerald Advisers reported no remaining Dermira, Inc. position as of Q1 2018 after selling out during the quarter.
Emerald Advisers sold 536,425 Dermira, Inc. shares in Q1 2018, an estimated $14.9M.
Emerald Advisers first reported a position in Dermira, Inc. in Q4 2017 and held it in 1 quarter.
Emerald Advisers's Dermira, Inc. position peaked at $14.9M in Q4 2017.
128 funds tracked by Wall St. Rank held Dermira, Inc. as of Q1 2018.

Based on Emerald Advisers's 13F filing for Q1 2018, filed 26 Apr 2018.